{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:31:25Z","timestamp":1793727085889,"version":"4.6.1"},"reference-count":128,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"publisher","award":["21-39625\u2009L"],"award-info":[{"award-number":["21-39625\u2009L"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"FWF Austrian Science Fund","doi-asserted-by":"publisher","award":["10.55776\/I5406"],"award-info":[{"award-number":["10.55776\/I5406"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["FE2166\/1\u20101"],"award-info":[{"award-number":["FE2166\/1\u20101"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Helmholtz Innovation Pool","award":["FISCOV"],"award-info":[{"award-number":["FISCOV"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2026,1,2]]},"DOI":"10.1080\/13543776.2025.2588773","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T15:55:58Z","timestamp":1764950158000},"page":"91-109","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["A patent review of Mpro protease inhibitors for the treatment of COVID-19 infections (2020 \u2013 present)"],"prefix":"10.1080","volume":"36","author":[{"given":"V\u00e1clav","family":"Mik","sequence":"first","affiliation":[{"name":"Palack\u00fd University Olomouc","place":["Olomouc, Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila S.","family":"Benz","sequence":"additional","affiliation":[{"name":"Macromolecular Crystallography, Helmholtz-Zentrum Berlin f\u00fcr Materialien und Energie","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Voller","sequence":"additional","affiliation":[{"name":"Palack\u00fd University Olomouc","place":["Olomouc, Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresia","family":"Dunzendorfer-Matt","sequence":"additional","affiliation":[{"name":"Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred S.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Macromolecular Crystallography, Helmholtz-Zentrum Berlin f\u00fcr Materialien und Energie","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladim\u00edr","family":"Kry\u0161tof","sequence":"additional","affiliation":[{"name":"Palack\u00fd University Olomouc","place":["Olomouc, Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04188-6"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2025.2480633"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-023-00692-8"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-021-00630-8"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1039\/d1cb00135c"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf8711"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2022.101159"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-023-00672-y"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.4c03023"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb3405"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2223-y"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167118"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1085658"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1835675100"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abo7201"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202016961"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103579"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115772"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1039\/d3md00493g"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107380"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116788"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2025.118247"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.108079"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05514-2"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4857"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add7197"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade8778"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012522"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.105969"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115491"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01692-5"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01770-y"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c01404"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm060325b"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18233-x"},{"key":"e_1_3_5_38_1","unstructured":"Chen X Wang J Huang J et al. Inventors; Guangdong Raynovent Biotech Co. Ltd. assignee. Ketoamide derivative and application thereof CN115594734A. 2023."},{"key":"e_1_3_5_39_1","unstructured":"Congreve MS Christopher JA Pickworth M et al. Inventors; Heptares Therapeutics Ltd. assignee. SARS-CoV-2 Mpro inhibitor compounds WO2022208113A1. 2022."},{"key":"e_1_3_5_40_1","unstructured":"Congreve MS Christopher JA Pickworth M et al. Inventors; Heptares Therapeutics Ltd. assignee. SARS-CoV-2 Mpro inhibitor compounds US2024083845A1. 2024."},{"key":"e_1_3_5_41_1","unstructured":"Congreve MS Christopher JA Pickworth M et al. Inventors; Heptares Therapeutics Ltd. assignee. SARS-CoV2 Mpro inhibitors and uses thereof WO2024074651A1. 2024."},{"key":"e_1_3_5_42_1","unstructured":"Campbell BT Chang W Hartingh TJ et al. Inventors; Merck Sharp & Dohme LLC assignee. Protease inhibitors for treating or preventing coronavirus infection WO2023133174A1. 2023."},{"key":"e_1_3_5_43_1","unstructured":"Wang J Ma C inventors; Arizona Board of Regents on behalf of the University of Arizona assignee. Small molecule inhibitors of SARS-CoV-2 viral replication and uses thereof WO2021207409A2. 2021."},{"key":"e_1_3_5_44_1","unstructured":"Richter W Abbas M Weber L et al. Inventors; Anixa Biosciences Inc. assignee. Mpro cysteine protease inhibitors WO2022040186A1. 2022."},{"key":"e_1_3_5_45_1","unstructured":"Liu H Li J Peng J et al. inventors; Shanghai Institute of Materia Medica Chinese Academy of Sciences assignee. Pharmaceutical use of ketoamide-based compound CA3166596A1. 2021."},{"key":"e_1_3_5_46_1","unstructured":"Yang S Li L. Inventors; Westvac Biopharma Co. Ltd. assignee. Keto amide derivatives and pharmaceutical use thereof WO2023165334A1. 2023."},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01063"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.121.000801"},{"key":"e_1_3_5_49_1","unstructured":"Owen DR Pettersson MY Reese MR et al. Inventors; Pfizer Inc. assignee. Nitrile-containing antiviral compounds WO2021250648A1. 2021"},{"key":"e_1_3_5_50_1","unstructured":"Chen S Yang Y Zhang J et al. Inventors; Medshine Discovery Inc. assignee. Ring-modified proline short peptide compound and use thereof WO2022218442A1. 2022"},{"key":"e_1_3_5_51_1","unstructured":"Chen S Cole AG Dorsey BD et al. Inventors; Arbutus Biopharma Corp. assignee. Main protease (Mpro) inhibitors and methods using same WO2023055702A1. 2023."},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.106038"},{"key":"e_1_3_5_53_1","unstructured":"Arnold LD Jennings A Keung W. Inventors; Pardes Biosciences Inc. assignee. Inhibitors of cysteine proteases and methods of use thereof US11124497B1. 2021."},{"key":"e_1_3_5_54_1","unstructured":"Richards S Derudas M Ahlsten N et al. Inventors; Exscientia AI Limited assignee. Mpro targeting antiviral compounds WO2023180189A1. 2023."},{"key":"e_1_3_5_55_1","unstructured":"Rogovoy B Kysil V Berishvili V et al. Inventors; Trawsfynydd therapeutics Inc. assignee. Compounds for treatment a coronavirus infection WO2023245162A2. 2023."},{"key":"e_1_3_5_56_1","unstructured":"Liu WR Xu S Alugubelli YR et al. Inventors; the Texas A&M University System assignee. SARS-CoV-2 Mpro inhibitors WO2024102986A2. 2024."},{"key":"e_1_3_5_57_1","unstructured":"Bardiot D-E Boland S Marchand ADM et al. Inventors; Aligos Therapeutics Inc. Katholieke Universiteit Leuven assignee. Anti-viral compounds US20240182444A1. 2024."},{"key":"e_1_3_5_58_1","unstructured":"Peng C Song G Wu J et al. Inventors; Suzhou Ark Biopharmaceutical Co. Ltd. assignee. Compound for preventing and treating coronavirus infection conjugate thereof and method therefor WO2023125846A1. 2023."},{"key":"e_1_3_5_59_1","unstructured":"Schofield CJ Brewitz L inventors; Oxford University Innovation Ltd assignee. Nirmatrelvir analogs as 3C like protease inhibitors for treating viral infections WO2024149990A1. 2024."},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c01627"},{"key":"e_1_3_5_61_1","unstructured":"He G Chen X Fan W et al. Inventors; Shanghai CureGene Pharmaceutical Co. Ltd. assignee. Anticoronviral compounds and compositions and uses thereof WO2023125825A1. 2023."},{"key":"e_1_3_5_62_1","unstructured":"See YY Low CH Tan LH et al. Inventors; Agency for Science Technology and Research assignee. 3CLpro inhibitors and methods thereof WO2024232829A1. 2024."},{"key":"e_1_3_5_63_1","unstructured":"Yang S Li L. Inventors; Sichuan University assignee. Novel coronavirus main protease inhibitor and preparation method therefor and use thereof wo2022021841a1. 2022."},{"key":"e_1_3_5_64_1","unstructured":"Wang J. Inventors; Arizona Board of Regents on behalf of the University of Arizona assignee. Compositions and methods for inhibiting Mpro and PLpro protease activity and for preventing and treating SARS-CoV-2 infection US11866407B2. 2024."},{"key":"e_1_3_5_65_1","unstructured":"Carney D Chang E Komandla M et al. Inventors; Takeda pharmaceutical Co. Ltd. Schrodinger Inc. assignee. Preparation of 3-[(1H-indol-2-yl)carbonyl]-6 6-dimethyl-N-[(S)-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-2-carboxamide derivatives as Mpro inhibitors for treatment of coronavirus infections WO2024059087A1. 2024."},{"key":"e_1_3_5_66_1","unstructured":"Liu H Li J Xie X et al. inventors; Shanghai Institute of Materia Medica Chinese Academy of Sciences assignee. Aldehyde group compounds preparation method therefor pharmaceutical compositions thereof and use thereof WO2021223718A1. 2021."},{"key":"e_1_3_5_67_1","unstructured":"Liu W Fierke CA Xu S et al. inventors; The Texas A&M University System assignee. SARS-CoV-2 main protease inhibitors WO2022020711A1. 2022."},{"key":"e_1_3_5_68_1","unstructured":"Liu H Li J Dai W et al. Inventors; Shanghai Institute of Materia Medica Chinese Academy of Sciences Frontier Biotechnologies Inc. assignee. Pharmaceutical use of aldehyde-based compound US20230138310A1. 2023."},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb4489"},{"key":"e_1_3_5_70_1","unstructured":"Thompson PR Mondal S. Inventors; University of Massachusetts assignee. Novel main protease inhibitors and compositions and methods thereof WO2023235109A1. 2023."},{"key":"e_1_3_5_71_1","unstructured":"Caffrey CR O\u2019Donoghue AJ Serafim MSM. Inventors; the Regents of the University of California assignee. Methods for inhibition of viral infection WO2024263680A1. 2024."},{"key":"e_1_3_5_72_1","unstructured":"Salvino J Montaner L Tietjen I et al. Inventors; the Wistar Institute of Anatomy and Biology assignee. Novel and highly selective SARS-CoV-2 mpro inhibitors WO2023150790A2. 2023."},{"key":"e_1_3_5_73_1","unstructured":"Hoffman RL Kania RS Owen DR et al. Inventors; Pfizer Inc. assignee. Method of treating COVID-19 US2023105838A1. 2023."},{"key":"e_1_3_5_74_1","unstructured":"He X Zhou T Cui M et al. inventors; Academy of Military Medical Science assignee. Sulfur-containing peptidomimetic compound and preparation method therefor and use thereof WO2024222830A1. 2024."},{"key":"e_1_3_5_75_1","unstructured":"Mao L Xu X Shaabani N et al. Inventors; Acea Therapeutics Inc. assignee. Protease inhibitors as antivirals WO2022256434A1. 2022."},{"key":"e_1_3_5_76_1","unstructured":"Hoffman RL Kania RS Nieman JA et al. Inventors; Pfizer Inc. assignee. Anticoronviral compounds and compositions their pharmaceutical uses and materials for their synthesis WO2005113580A1. 2005."},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01348-12"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00117"},{"key":"e_1_3_5_79_1","unstructured":"Tachibana Y Uehara S Unoh Y et al. Inventors; Shionogi & Co. Ltd. National University corporation Hokkaido University assignee. Triazine derivative having virus propagation inhibitory effect and pharmaceutical composition containing same WO2022138987A1. 2022"},{"key":"e_1_3_5_80_1","unstructured":"Shimizu R Matsuo Y Fukuhara T et al. Inventors; Shionogi & Co. Ltd. assignee. Pharmaceutical for treating novel coronavirus infection US20250099474A1. 2025."},{"key":"e_1_3_5_81_1","unstructured":"Yano R Yamamoto A Nobori H et al. Inventors; Shionogi & Co. Ltd. assignee. COVID-19 treatment medicine characterized by combining 3CL protease inhibitor and COVID-19 treatment drug US20250025459A1. 2025."},{"key":"e_1_3_5_82_1","unstructured":"Xie X Zhang D Ma Z et al. Inventors; Shaanxi Panlong Pharmaceutical Co. Ltd. Xixian New District Fenghou Original Pharmaceutical Technology Co. Ltd. assignee. 3-tetrazolylmethyl-1 3 5-triazin-2 4-dione compound inhibiting coronavirus 3CL protease activity and preparation method and use thereof US12221424B2. 2025."},{"key":"e_1_3_5_83_1","unstructured":"Zhang H Yang Q Zhang W et al. Inventors; Guangzhou National Laboratory Beijing Stonewise Technology Co. Ltd. assignee. 3C-like protease inhibitor WO2023227117A1. 2023."},{"key":"e_1_3_5_84_1","unstructured":"Zhang H Yang Q Zhang W et al. Inventors; Guangzhou National Laboratory Beijing Stonewise Technology Co. Ltd. assignee. 3C-like protease inhibitor WO2023227118A1. 2023."},{"key":"e_1_3_5_85_1","unstructured":"Ana Nd R Bookser BC Shapiro N et al. Inventors; Vir Biotechnology Inc. assignee. Modulators of coronavirus 3C-like protease and uses thereof WO2025058977A1. 2025."},{"key":"e_1_3_5_86_1","unstructured":"Jorgensen WL inventors; Yale University assignee. Non-covalent inhibitors of the main protease of SARS-CoV-2 and methods of use WO2022150584A1. 2022."},{"key":"e_1_3_5_87_1","unstructured":"Jorgensen WL inventors; Yale University assignee. Non-covalent inhibitors of the main protease of SARS-CoV-2 and methods of use WO2024010585A1. 2024."},{"key":"e_1_3_5_88_1","unstructured":"Liotta DC Pelly SC Jacobs L et al. Inventors; Emory University assignee. Non-covalent inhibitors of coronavirus main protease WO2024102455A1. 2024."},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.3c00335"},{"key":"e_1_3_5_90_1","unstructured":"Sato J Shibayama H Hirai K et al. Inventors; Shionogi & Co. Ltd. assignee. Uracil derivative having viral growth inhibitory activity and pharmaceutical composition containing same WO2023195529A1. 2023"},{"key":"e_1_3_5_91_1","unstructured":"Jiang X Xu Y Zhang L et al. Inventors; Shanghai Institute of Materia Medica Chinese Academy of Sciences Wuhan Institute of Virology Chinese Academy of Sciences Simcere Pharmaceutical Co. Ltd. assignee. Cyano compound and preparation method therefor and use thereof US20240408065A1. 2024"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42102-y"},{"key":"e_1_3_5_93_1","unstructured":"Wang G Shen R He Y et al. Inventors; Enanta Pharmaceuticals Inc. assignee. Novel spiropyrrolidine derived antiviral agents WO2022109363A1. 2022."},{"key":"e_1_3_5_94_1","unstructured":"Zhu K Wang T Helble J et al. inventors; Enanta Pharmaceuticals Inc. assignee. Crystal forms of an anti-SARS CoV-2 agent WO2024076680A1. 2024."},{"key":"e_1_3_5_95_1","unstructured":"Lai Y Xiong J Xiao Y et al. Inventors; Shenzhen Salubris Pharmaceuticals Co. Ltd. assignee. Spiro compound and preparation method therefor and use thereof WO2024017270A1. 2023."},{"key":"e_1_3_5_96_1","unstructured":"He G Hou K Wu H et al. Inventors; Shanghai Curegene Pharmaceutical Co. Ltd. assignee. Anticoronviral compounds and compositions and uses thereof WO2025011656A1. 2025."},{"key":"e_1_3_5_97_1","unstructured":"Khan MA. Inventors; Aptinyx Inc. assignee. Spiro-lactam compounds and methods of treating viral infections using the same WO2021247880A2. 2021."},{"key":"e_1_3_5_98_1","unstructured":"Carlsson J Danielson H Moodie L et al. Inventors; Carlsson J. Danielson H. Moodie L. Sandstr\u00f6m A. assignee. Substituted hydantoin compounds methods for preparation thereof and use thereof in the treatment and\/or prevention of a corona virus disease WO2022229458A1. 2022."},{"key":"e_1_3_5_99_1","unstructured":"Hesse MJ Hornak V Joseph S et al. Inventors; Novartis AG assignee. Compounds and compositions for the treatment of coronaviral related diseases WO2022224223A1. 2022."},{"key":"e_1_3_5_100_1","unstructured":"Bao D Guo F Hesse MJ et al. Inventors; Novartis AG assignee. Compounds and compositions for the treatment of coronaviral related diseases WO2023002409A1. 2023."},{"key":"e_1_3_5_101_1","unstructured":"Ammann SE Cai X Canales EY et al. inventors; Gilead Sciences Inc. assignee. SARS-CoV2 main protease inhibitors US12091420B2. 2024."},{"key":"e_1_3_5_102_1","unstructured":"Stauffer SR MacDonald JD Hooper A et al. inventors; The Cleveland Clinic Foundation assignee. Protease inhibitors and methods of use WO2022266368A1. 2022."},{"key":"e_1_3_5_103_1","unstructured":"Stauffer SR Han SH Hooper A et al. inventors; The Cleveland Clinic Foundation assignee. Protease inhibitors and methods of use WO2022226203A1. 2022."},{"key":"e_1_3_5_104_1","unstructured":"Liu WR Xu S Alugubelli YR et al. inventors; The Texas A&M University System assignee. Non-peptidic SARS-CoV-2 main protease inhibitors WO2024102989A1. 2024."},{"key":"e_1_3_5_105_1","unstructured":"Yu H Hu Q Huang J et al. Inventors; Westlake University assignee. Protease inhibitors and preparation method and use thereof CN113072497A. 2021."},{"key":"e_1_3_5_106_1","unstructured":"Rolfe J Khodabandeh M Alperstein Z et al. Inventors; Variational AI Inc. assignee. Protease inhibitors and methods of making same US20240228460A1. 2024."},{"key":"e_1_3_5_107_1","unstructured":"Rolfe J Khodabandeh M Alperstein Z et al. Inventors; Variational AI Inc. assignee. Protease inhibitors and methods of using same WO2024130411A1. 2024."},{"key":"e_1_3_5_108_1","unstructured":"Degoey DA Schrimpf MR Hardee DJ et al. inventors; Abbvie Inc. assignee. Pyrrolidine main protease inhibitors as antiviral agents WO2024081351A1. 2024"},{"key":"e_1_3_5_109_1","unstructured":"Shen A Yu X Tao H et al. Inventors; Guangzhou Medical University assignee. Application of tetrahydroquinolone-amide-thiazole compounds au2024204967b1. 2024."},{"key":"e_1_3_5_110_1","unstructured":"Zhou Y Li J Zhang L et al. inventors; Shanghai Institute of Materia Medica Chinese Academy of Sciences Wuhan Institute of Virology Chinese Academy of Science assignee. Quinolinone amide-containing compound preparation method therefor pharmaceutical composition thereof and use thereof WO2023030459A1. 2023."},{"key":"e_1_3_5_111_1","unstructured":"Ochida A Chang E Carney D et al. inventors; Takeda Pharmaceutical Co. Ltd. Schrodinger Inc. assignee. Novel protease inhibitors for treatment of coronavirus infections WO2024107778A1. 2024."},{"key":"e_1_3_5_112_1","unstructured":"Sacchettini J Zhou NE Parai MK et al. Inventors; the Texas A&M University System assignee. Inhibitors of SARS-CoV-2 WO2022235813A1. 2022."},{"key":"e_1_3_5_113_1","unstructured":"Liu X Yang D Chen S et al. inventors; Heyuan Shenhe People\u2019s Hospital (the Fifth Affiliated Hospital of Jinan University) assignee. Polysubstituted piperazine compound with chiral center and its preparation method and application CN118955471A. 2024."},{"key":"e_1_3_5_114_1","unstructured":"Wang J Cheng C Chi B et al. Inventors; Shanghai Qilu Pharmaceutical Research and Development Centre Ltd. assignee. 3CLpro protease inhibitor WO2023036140A1. 2023."},{"key":"e_1_3_5_115_1","unstructured":"Chamakuri S Lu S Ucisik MN et al. inventors; Baylor College of Medicine assignee. Coronavirus main protease inhibitors and methods using same WO2023004291A1. 2023."},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2111172118"},{"key":"e_1_3_5_117_1","unstructured":"Shen Z Li Y Zhu J et al. inventors; WuXi AppTec (Shanghai) Co. Ltd. assignee. Virus main protease inhibitor preparation method therefor and use WO2023283831A1. 2023."},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm301580n"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.3390\/v13020174"},{"key":"e_1_3_5_120_1","unstructured":"Wang J Kitamura N Ma C inventors; Arizona board of regents on behalf of the University of Arizona assignee. Compositions and methods for inhibiting Mpro protease activity and for preventing and treating SARS-CoV-2 infection WO2022119756A9. 2022."},{"key":"e_1_3_5_121_1","unstructured":"Sun D Zhang M Peng J et al. Inventors; Insilico Medicine IP Ltd. assignee. Mpro inhibitors for treating coronavirus infections WO2024174966A1. 2024."},{"key":"e_1_3_5_122_1","unstructured":"Arnold LD Lopatin U Keung W. Inventors; Pardes Biosciences Inc. assignee. Inhibitors of cysteine proteases and methods of use thereof WO2021212039A1. 2021."},{"key":"e_1_3_5_123_1","unstructured":"Deplano A Sabbadin D Piquemal J-P et al. inventors; Qubit Pharmaceuticals Centre National de la Recherche Scientifique Sorbonne Universit\u00e9 assignee. Novel inhibitors of coronaviruses 3-chymotrypsin-like protease WO2023052638A1. 2023."},{"key":"e_1_3_5_124_1","unstructured":"Shi D Li X Wang X et al. inventors; Lead high technology (Qingdao) Co. Ltd. assignee. Bromophenol-pyrazoline compound and synthesis method and use thereof US11820763B2. 2023."},{"key":"e_1_3_5_125_1","unstructured":"Toyama T Arisawa M Saito Y et al. Inventors; Tohoku University assignee. Antiviral agent WO2024185864A1. 2024."},{"key":"e_1_3_5_126_1","unstructured":"Rana TM inventors; The regents of the University of California assignee. Methods and compounds to treat SARS infections WO2022081984A1. 2022."},{"key":"e_1_3_5_127_1","unstructured":"Maple H Marsh G Moloney A et al. inventors; Tocris Cookson Ltd. Helmholtz Zentrum f\u00fcr Infektionsforschung GmbH Universit\u00e4t zu L\u00fcbeck assignee. Protacs useful against the main protease SARS-CoV-2 WO2024074848A1. 2024."},{"key":"e_1_3_5_128_1","unstructured":"Han Y Wu S inventors; Protacs targeting viral enzymes for precise treatment of COVID-19 WO2024086132A1. Ohio University assignee. 2024."},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116202"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c02416"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2025.2588773","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:47:54Z","timestamp":1776944874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2025.2588773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":128,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"alternative-id":["10.1080\/13543776.2025.2588773"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2025.2588773","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-07-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}